In the present work, oil in water (o/w) cream based drug formulations were designed and prepared for the treatment of psoriasis affecting 1% to 2% of people in general. In the study, fluocinolone acetonide is chosen as the drug which is an effective topical corticosteroid. These formulations were subjected to various physiochemical parameters like spreadability, tube extrudability, pH, drug content, viscosity, infra-red (IR) studies and In vitro drug release studies. Fourier Transform-Infrared (FT-IR) study revealed no interaction between the drug and exciepients. Totally nine formulations were prepared. Among the nine formulations, F8 was selected as the best formulation which is produced in three batches with process variables. The pH of all batches ranges from 6.5 to 6.7, drug content from 96% to 99%, spreadability and tube extrudability ranges from 17.02 gm.cm/sec to 17.84 gm.cm/sec and 98.10% to 98.71% respectively. The formulation F8 batch-II showed maximum drug release 97.42% when compared to other batches. Stability studies of selected formulations were also done at temperatures of 40 ºC/ 75 RH and 25 ºC/60 RH for the period of three months and results showed no significant changes in physico-chemical parameters. In vivo studies on wistar rats was performed and the result showed that the formulations are devoid of any primary skin irritation. Present study revealed that fluocinolone acetonide o/w cream formulation should be useful for treatment of psoriasis.
Introduction
The skin is the largest and the most visible organ of human body but, for people with skin disease, this visibility is often the worst aspect of their condition. These may have an impact on various aspects, such as physical disability, social functioning, work and school, recreation, family and personal relationship [1] .
Psoriasis is an autoimmune disease that appears on the skin. It occurs when the immune system mistakes the skin cells as a pathogen, and sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis is not contagious. Psoriasis is a common chronic inflammatory dermatosis characterized by well-demarcated, pink to salmon-coloured by loosely adherent scales that are characterized silver white in colour. Prevalence of psoriasis varies in different parts of the world in different populations from 0 % to 11.8 % [2] . Topical corticosteroids are the powerful anti-inflammatory drugs which are the most frequently prescribed medications for treating mild to moderate psoriasis. They slow cell turnover by suppressing the immune system, which reduces inflammation and relieves associated itching [3] . Fluocinolone acetonide is a Glucocorticoids derivative used topically in the treatment of various skin Advances in Biomedicine and Pharmacy (An International Journal of Biomedicine, Natural Products and Pharmacy) disorders. It is usually employed as a cream, gel, lotion, or ointment [4] . Patient compliance is often poor as currently available medications are often greasy, sticky, odorous, difficult to apply, require frequent application, and are expensive. In proposed work it is planned to prepare o/w cream formulations which is non-greasy and water removable, increasing patient's compliance. In the study an attempt has been made to prepare cream preparation of fluocinolone acetonide using different bases in order to produce desired cream properties and increase patient compliance. 
Materials and Methods

Materials
Evaluation of o/w cream
The o/w cream was evaluated for pH, drug content, viscosity, spreadability, tube extrudability, drug diffusion, stability and primary skin irritation test on experimental animals (wistar rats). [5] Accurately 5± 0.01 gm of the cream was taken in 100 ml beaker. To which 45 ml of water was added and dispersed the cream in it. The pH of suspension at 27 o C using the pH meter was determined.
Determination of pH
Preparation of o/w cream formulation:
These o/w emulsion based preparations containing aqueous phase and oil phase. Mobile solvent: A mixture of water and acetonitrile (5:3) was prepared. Adjust the ratio as necessary to obtain suitable chromatographic performance.
Assay preparation: Accurately weighed portion of cream was dissolved, equivalent to about 0.75 mg of fluocinolone acetonide, in about 10 ml of acetonitrile by heating on steam bath. Transfer mixture to 25 ml volumetric flask with aid of three 2 ml portions of acetonitrile. 0.3 ml of internal standard solution was added, mixed and cooled in an ice bath. The mixture was centrifuged and filtered to obtain a clear solution.
Apparatus: HPLC general type with detector monitoring absorbance at 254 nm with flow rate 2 ml/min for mobile solvent. Column using L1 packing C18.
Viscosity [6] The viscosity of formulated o/w cream was measured by Brook field Viscometer (LVDV-II+ pro viscometer) using T shaped spindle -96 at varying speed and shear rates. The measurements were made over the range of speed setting from 0.10, 0.50, 1, 1.5 rpm with 60 sec between two successive speeds as equilibration with shear rate ranging from 0.20 sec-1 to 1.0 sec-1. The values were noted at three points top, middle and bottom as the spindle moved down. Viscosity determinations were performed at room temperature.
The viscosity data was plotted for Rheogram, in Figures 1 to 3.
Spreadability [7] Spreadability is a term expressed to denote the extent of area to which the topical application spreads on application to skin on the affected parts. The therapeutic efficiency of the formulation also depends upon its spreading value. Hence, determination of spreadability is very important in evaluating topical application characteristics. For the determination of spreadability, excess of sample (3 gm) was applied in between two glass slides and was compressed to uniform thickness by placing 1000 gm weight for 5 minute. Thereafter weight (50 gm) was added to the pan and the top plate was subjected to pull with the help of string attached to the hook. The time in which the upper glass slide moves the lower plate to cover a distance of 10 cm is noted. A shorter interval indicates better spread ability.
The spread ability (S) can be calculated by using the formula S = m.l/t
Where, S -spread ability; m-weight tied to upper glass slide; l-length moved on glass slide; t-time taken.
Tube extrudability [8] In the present study, the method adopted for evaluating cream formulation for extrudability was based upon the quantity in percentage cream extruded from tube on application of finger pressure. More quantity extruded better was extrudability. The formulations under study was filled in a clean, lacquered aluminum collapsible 5 g tube with a nasal tip of 5mm opening and apply the pressure on the tube by the help of finger. Tube extrudability was then determined by measuring the amount of cream extruded through the tip when a pressure was applied on tube.
In-vitro Drug diffusion [9]
A glass cylinder with both ends open, 10 cm height, 3.7 cm outer diameter and 3.1 cm inner diameter was used as permeation cell. A cellophane membrane prehydrated in pH 7.4 buffer (24 h before use) was fixed to the one end of the cylinder with the aid of an adhesive to result in permeation cell. One gram of semisolid formulation was taken in the cell (donor compartment) and the cell was attached to beaker containing 100 ml of drug free pH 7.4 phosphate buffers as receptor compartment. The medium in the receptor compartment was agitated using a magnetic stirrer and temperature of 37ºC ± 1ºC was maintained. Samples (5 ml) of the receptor compartment were taken at various intervals over a period of 3 h with replacement of equal amount of free receptor fluid. The samples were estimated by measuring the absorbance at 254 nm in a 2450 UV Shimadzu spectrophotometer.
Stability studies [10] The prepared 0.025 % o/w cream formulation were filled in the collapsible tubes and stored at 25 ºC/60RH and 40 ºC/75 RH temperatures for the span of three months. 1gm of cream formulation was taken out at different time intervals (one month interval) and analyzed for drug content, physical appearance, pH and rheological properties.
Infrared spectral analysis [8] IR spectral analysis is one of the most powerful analytical techniques which offer the possible chemical identification. In the present work, IR spectrum of fluocinolone acetonide pure drug and fluocinolone acetonide with other exciepients in formulation was studied for their interactions.
Primary skin irritation test [11]
Laboratory experimental animals
The animals selected were wistar rats after getting approval from The Institutional Animal Ethical Committee (IAEC) of The Oxford College of Pharmacy. These animals were kept in different cages and supplied with fresh food and water during the test period, 24 h prior to test, and the hair from the neck and thigh region was shaved to expose sufficient large test area. The test site was cleaned with surgical spirit then o/w cream was applied to test area. The test site was observed for erythema and edema for 24 h; 48 h and 72 h after application. This test was conducted to evaluate the irritancy of the prepared cream on the intact skin of animals.
Results and Discussion:
In the present work, cream based drug formulations were designed and prepared for the treatment of psoriasis which is a common chronic inflammatory dermatosis. In the study, fluocinolone acetonide is chosen as the drug which is an effective topical corticosteroid. Totally nine formulations were prepared (Table. 2). Among the nine formulations, F8 was selected as the best formulation which is produced in three batches with process variables (Tables 3 and 4) . The pH of all batches ranged from 6.5 to 6.7, drug content from 96% to 99%, spreadability and tube extrudability ranges from 17.02 gm.cm/sec to 17.84 gm.cm/sec and 98.10% to 98.71% respectively. The data plotted for viscosity Vs shear rate showed down curves. This graph indicated that system is pseudoplastic (shear thinning) in nature (Fig. 1) .The formulation F8 batch-II showed maximum drug release 97.42% when compare to other batches (Fig-1) and was selected as the most suitable formulation. Stability studies of selected formulations were also done at temperatures 40ºC/75RH and 25ºC/60RH for the period of three months as per ICH guidelines and they passed stability studies with no much significant changes in physic-chemical parameters (Table. 5 and 6 ). All the FT-IR peaks of the pure drug are also observed in the optimised formulation with slight modification (Figure 4) . In vivo studies on wistar rats was performed and the result showed that the formulations are devoid of any primary skin irritation ( Figure 5 ). 
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